LifeVantage (LFVN) announced the results of a third-party cell study on the synergistic impact of Protandim Nrf2 Synergizer ...
Corporation (NASDAQ:LFVN), a company specializing in nutrigenomics, announced the appointment of Todd Thompson as its new Chief Information and Innovation Officer. The company, which has demonstrated ...
Fintel reports that on January 14, 2025, Craig-Hallum initiated coverage of LifeVantage (NasdaqCM:LFVN) with a Buy ...
LifeVantage Corporation (Nasdaq: LFVN), a leader in cellular activation of optimal health processes, today announced the results of a groundbreaking third-party cell study on the synergistic impact of ...